Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,061
Closed -$955K 760
2022
Q4
$955K Sell
18,061
-64,017
-78% -$3.16M ﹤0.01% 508
2022
Q3
$3.63M Sell
82,078
-44,903
-35% -$2.22M 0.01% 328
2022
Q2
$6.34M Sell
126,981
-60,155
-32% -$2.93M 0.03% 208
2022
Q1
$9.74M Buy
+187,136
New +$9.66M 0.04% 155
2021
Q1
Sell
-23,574
Closed -$1.32M 544
2020
Q4
$1.32M Buy
23,574
+4,588
+24% +$245K 0.01% 341
2020
Q3
$1.05M Buy
+18,986
New +$985K 0.01% 294

Other funds holding QGEN

Brookfield Corp's QGEN Position: Q1 2023 in Review

Brookfield Corp sold out of Qiagen (QGEN) in Q1 2023, closing a stake of 18,061 shares — an estimated $955K sold.

Brookfield Corp first reported a position in QGEN in Q3 2020 and held it in 6 quarters. The position peaked at $9.74M in Q1 2022. 287 funds tracked by Wall St. Rank hold QGEN as of Q1 2023.

  • Brookfield Corp reported no remaining Qiagen position as of Q1 2023 after selling out during the quarter.
  • Brookfield Corp sold 18,061 Qiagen shares in Q1 2023, an estimated $955K.
  • Brookfield Corp first reported a position in Qiagen in Q3 2020 and held it in 6 quarters.
  • Brookfield Corp's Qiagen position peaked at $9.74M in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Qiagen as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.